Conference
780PD Interim analysis of a phase I dose escalation trial of the antibody drug conjugate (ADC) AGS15E (ASG-15ME) in patients (Pts) with metastatic urothelial cancer (mUC)
Authors
Petrylak D; Heath E; Sonpavde G; George S; Morgans AK; Eigl BJ; Picus J; Cheng S; Hotte SJ; Gartner E
Volume
27
Publisher
Elsevier
Publication Date
October 1, 2016
DOI
10.1093/annonc/mdw373.08
Conference proceedings
Annals of Oncology
ISSN
0923-7534